NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 184)
Posted On: 06/14/2022 3:43:14 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and other industries, today announced a pivotal peer-reviewed scientific publication. The piece highlights the use of PBI’s patented Ultra Shear Technology(TM) (“UST(TM)”) platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University College of Food, Agricultural and Environmental Sciences (“CFAES”), in a study published in the high impact journal Food Hydrocolloids, reported that UST successfully created stable suspensions of milk-pea protein blends in microscopic particle sizes — the objective required for commercially-suitable products. This reflects a significant achievement that could not be reached through existing high-pressure processing (“HPP”) or thermal processing techniques alone.
“The quest for finding alternative beverages that are healthier and environmentally sustainable but also appealing to the palate — such as plant protein-based drinks — is a rapidly growing market estimated to reach $41B by 2027 (MDC Market Report),” said Richard T. Schumacher, president and CEO of PBI. “We are currently in discussions with industry leaders in this market, as well as companies that want to use UST to make high quality nanoemulsions to add vitamins, antioxidants, nutraceuticals, etc. to their beverages. The recent Ohio State results on UST-processed micro/nano plant protein milk suspensions, as well as previously released data om UST-enhanced nanoemulsions, support our confidence that UST has the potential to become an essential tool in future beverage development, as well as in other health-related and consumer markets (TechTalks Video). We continue to look forward to the planned Q3/Q4 2022 commercial release of the UST platform.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and other industries, today announced a pivotal peer-reviewed scientific publication. The piece highlights the use of PBI’s patented Ultra Shear Technology(TM) (“UST(TM)”) platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University College of Food, Agricultural and Environmental Sciences (“CFAES”), in a study published in the high impact journal Food Hydrocolloids, reported that UST successfully created stable suspensions of milk-pea protein blends in microscopic particle sizes — the objective required for commercially-suitable products. This reflects a significant achievement that could not be reached through existing high-pressure processing (“HPP”) or thermal processing techniques alone.
“The quest for finding alternative beverages that are healthier and environmentally sustainable but also appealing to the palate — such as plant protein-based drinks — is a rapidly growing market estimated to reach $41B by 2027 (MDC Market Report),” said Richard T. Schumacher, president and CEO of PBI. “We are currently in discussions with industry leaders in this market, as well as companies that want to use UST to make high quality nanoemulsions to add vitamins, antioxidants, nutraceuticals, etc. to their beverages. The recent Ohio State results on UST-processed micro/nano plant protein milk suspensions, as well as previously released data om UST-enhanced nanoemulsions, support our confidence that UST has the potential to become an essential tool in future beverage development, as well as in other health-related and consumer markets (TechTalks Video). We continue to look forward to the planned Q3/Q4 2022 commercial release of the UST platform.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼